• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于图像的共识分子亚型(imCMS)分类用于结直肠癌的深度学习。

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.

机构信息

Institute of Biomedical Engineering (IBME), Department of Engineering Science, University of Oxford, Oxford, UK.

Big Data Institute, University of Oxford, Li Ka Shing Centre for Health Information and Discovery, Oxford, UK.

出版信息

Gut. 2021 Mar;70(3):544-554. doi: 10.1136/gutjnl-2019-319866. Epub 2020 Jul 20.

DOI:10.1136/gutjnl-2019-319866
PMID:32690604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7873419/
Abstract

OBJECTIVE

Complex phenotypes captured on histological slides represent the biological processes at play in individual cancers, but the link to underlying molecular classification has not been clarified or systematised. In colorectal cancer (CRC), histological grading is a poor predictor of disease progression, and consensus molecular subtypes (CMSs) cannot be distinguished without gene expression profiling. We hypothesise that image analysis is a cost-effective tool to associate complex features of tissue organisation with molecular and outcome data and to resolve unclassifiable or heterogeneous cases. In this study, we present an image-based approach to predict CRC CMS from standard H&E sections using deep learning.

DESIGN

Training and evaluation of a neural network were performed using a total of n=1206 tissue sections with comprehensive multi-omic data from three independent datasets (training on FOCUS trial, n=278 patients; test on rectal cancer biopsies, GRAMPIAN cohort, n=144 patients; and The Cancer Genome Atlas (TCGA), n=430 patients). Ground truth CMS calls were ascertained by matching random forest and single sample predictions from CMS classifier.

RESULTS

Image-based CMS (imCMS) accurately classified slides in unseen datasets from TCGA (n=431 slides, AUC)=0.84) and rectal cancer biopsies (n=265 slides, AUC=0.85). imCMS spatially resolved intratumoural heterogeneity and provided secondary calls correlating with bioinformatic prediction from molecular data. imCMS classified samples previously unclassifiable by RNA expression profiling, reproduced the expected correlations with genomic and epigenetic alterations and showed similar prognostic associations as transcriptomic CMS.

CONCLUSION

This study shows that a prediction of RNA expression classifiers can be made from H&E images, opening the door to simple, cheap and reliable biological stratification within routine workflows.

摘要

目的

组织学切片上捕获的复杂表型代表了个体癌症中发生的生物学过程,但与潜在分子分类的联系尚未阐明或系统化。在结直肠癌(CRC)中,组织学分级是疾病进展的不良预测因子,并且在没有基因表达谱分析的情况下无法区分共识分子亚型(CMS)。我们假设图像分析是一种具有成本效益的工具,可以将组织学结构的复杂特征与分子和结果数据相关联,并解决无法分类或异质性的病例。在这项研究中,我们提出了一种基于图像的方法,使用深度学习从标准 H&E 切片预测 CRC CMS。

设计

使用来自三个独立数据集的 n=1206 个具有全面多组学数据的组织切片(FOCUS 试验训练,n=278 例患者;直肠活检 GRAMPIAN 队列,n=144 例患者;TCGA,n=430 例患者)对神经网络进行训练和评估。通过匹配随机森林和 CMS 分类器的单个样本预测,确定 CMS 调用的真实值。

结果

基于图像的 CMS(imCMS)准确地对 TCGA 中未见过的数据集中的切片进行分类(n=431 个切片,AUC=0.84)和直肠活检(n=265 个切片,AUC=0.85)。imCMS 空间分辨率肿瘤内异质性,并提供与分子数据的生物信息学预测相关的次要调用。imCMS 对 RNA 表达谱分析不可分类的样本进行分类,再现了与基因组和表观遗传改变的预期相关性,并显示出与转录组 CMS 相似的预后相关性。

结论

这项研究表明,可以从 H&E 图像中做出 RNA 表达分类器的预测,为常规工作流程中的简单、廉价和可靠的生物学分层开辟了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/937075171637/gutjnl-2019-319866f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/0f553780ff6b/gutjnl-2019-319866f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/cdcda748a67e/gutjnl-2019-319866f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/2be6c7589a41/gutjnl-2019-319866f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/937075171637/gutjnl-2019-319866f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/0f553780ff6b/gutjnl-2019-319866f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/cdcda748a67e/gutjnl-2019-319866f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/2be6c7589a41/gutjnl-2019-319866f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd84/7873419/937075171637/gutjnl-2019-319866f04.jpg

相似文献

1
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.基于图像的共识分子亚型(imCMS)分类用于结直肠癌的深度学习。
Gut. 2021 Mar;70(3):544-554. doi: 10.1136/gutjnl-2019-319866. Epub 2020 Jul 20.
2
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.从结直肠活检中对稳健的肿瘤细胞内在亚型进行前瞻性患者分层。
J Pathol. 2018 May;245(1):19-28. doi: 10.1002/path.5051. Epub 2018 Mar 25.
3
Consensus molecular subtype classification of colorectal adenomas.结直肠腺瘤的共识分子亚型分类。
J Pathol. 2018 Nov;246(3):266-276. doi: 10.1002/path.5129. Epub 2018 Aug 31.
4
Exon-Skipping-Based Subtyping of Colorectal Cancers.基于外显子跳跃的结直肠癌亚型分类。
Gastroenterology. 2024 Dec;167(7):1358-1370.e12. doi: 10.1053/j.gastro.2024.08.016. Epub 2024 Aug 23.
5
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.基于 microRNA 的结直肠癌分子亚型检测分类器的开发。
Mol Oncol. 2022 Jul;16(14):2693-2709. doi: 10.1002/1878-0261.13210. Epub 2022 Apr 29.
6
Feasibility of deep learning-based fully automated classification of microsatellite instability in tissue slides of colorectal cancer.基于深度学习的结直肠癌组织切片微卫星不稳定性全自动分类的可行性研究。
Int J Cancer. 2021 Aug 1;149(3):728-740. doi: 10.1002/ijc.33599. Epub 2021 Apr 27.
7
Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.结肠癌和直肠癌中的集落刺激因子3信号传导:TCGA数据中的免疫反应和CMS分类
PLoS One. 2021 Feb 19;16(2):e0247233. doi: 10.1371/journal.pone.0247233. eCollection 2021.
8
A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues.一种用于临床结直肠癌组织的共识分子亚型分类策略。
Life Sci Alliance. 2024 May 23;7(8). doi: 10.26508/lsa.202402730. Print 2024 Aug.
9
A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.采用免疫组织化学技术,建立改良的蛋白标志物面板以识别结直肠癌的四种共识分子亚型。
Pathol Res Pract. 2021 Apr;220:153379. doi: 10.1016/j.prp.2021.153379. Epub 2021 Mar 5.
10
Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.基于病理组学的结直肠癌微卫星不稳定性预测模型的建立与阐释。
Theranostics. 2020 Sep 2;10(24):11080-11091. doi: 10.7150/thno.49864. eCollection 2020.

引用本文的文献

1
Deep learning-driven whole-slide image analysis predicts chemo-resistance and motility subtypes in muscle-invasive bladder cancer.深度学习驱动的全切片图像分析可预测肌肉浸润性膀胱癌的化疗耐药性和运动亚型。
Genes Genomics. 2025 Sep 4. doi: 10.1007/s13258-025-01677-0.
2
Deep learning-driven multi-omics analysis: enhancing cancer diagnostics and therapeutics.深度学习驱动的多组学分析:增强癌症诊断与治疗
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf440.
3
New Insights into Personalized Surgical Oncology.个性化手术肿瘤学的新见解

本文引用的文献

1
Immunotherapy in colorectal cancer: rationale, challenges and potential.结直肠癌的免疫治疗:原理、挑战与潜能。
Nat Rev Gastroenterol Hepatol. 2019 Jun;16(6):361-375. doi: 10.1038/s41575-019-0126-x.
2
Artificial intelligence-the third revolution in pathology.人工智能——病理学的第三次革命。
Histopathology. 2019 Feb;74(3):372-376. doi: 10.1111/his.13760.
3
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.基于深度学习的非小细胞肺癌组织病理学图像分类和突变预测。
J Pers Med. 2025 Jul 8;15(7):295. doi: 10.3390/jpm15070295.
4
Recent advances and challenges in colorectal cancer: From molecular research to treatment.结直肠癌的最新进展与挑战:从分子研究到治疗
World J Gastroenterol. 2025 Jun 7;31(21):106964. doi: 10.3748/wjg.v31.i21.106964.
5
A quantitative tumor-wide analysis of morphological heterogeneity of colorectal adenocarcinoma.结直肠癌形态异质性的全肿瘤定量分析。
J Pathol Clin Res. 2025 Jul;11(4):e70034. doi: 10.1002/2056-4538.70034.
6
The Expression and Molecular Roles of MAMDC2 in MSS Colorectal Cancer with a High Tumor Stromal Ratio.MAMDC2在肿瘤基质比例高的微卫星稳定型结直肠癌中的表达及分子作用
Biomedicines. 2025 May 17;13(5):1217. doi: 10.3390/biomedicines13051217.
7
Defining a 'cells to society' research framework for appendiceal tumours.为阑尾肿瘤定义一个“细胞到社会”的研究框架。
Nat Rev Cancer. 2025 Apr;25(4):293-315. doi: 10.1038/s41568-024-00788-2. Epub 2025 Feb 20.
8
Prognosis in stage II colon cancer: Expanding the horizons of risk factors.II期结肠癌的预后:拓展风险因素的视野
World J Gastrointest Oncol. 2025 Feb 15;17(2):100552. doi: 10.4251/wjgo.v17.i2.100552.
9
Cancer molecular subtyping using limited multi-omics data with missingness.利用带有缺失值的有限多组学数据进行癌症分子亚型分类。
PLoS Comput Biol. 2024 Dec 26;20(12):e1012710. doi: 10.1371/journal.pcbi.1012710. eCollection 2024 Dec.
10
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.利用深度学习评估结直肠癌肿瘤纯度及其对分子分析的影响
J Pathol. 2025 Feb;265(2):184-197. doi: 10.1002/path.6376. Epub 2024 Dec 22.
Nat Med. 2018 Oct;24(10):1559-1567. doi: 10.1038/s41591-018-0177-5. Epub 2018 Sep 17.
4
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.从结直肠活检中对稳健的肿瘤细胞内在亚型进行前瞻性患者分层。
J Pathol. 2018 May;245(1):19-28. doi: 10.1002/path.5051. Epub 2018 Mar 25.
5
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.关键研究差距及建议,为结直肠癌更有效的预防和改善预后的研究优先级提供参考。
Gut. 2018 Jan;67(1):179-193. doi: 10.1136/gutjnl-2017-315333.
6
Tumour heterogeneity and resistance to cancer therapies.肿瘤异质性与癌症治疗耐药性。
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94. doi: 10.1038/nrclinonc.2017.166. Epub 2017 Nov 8.
7
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.用于结直肠癌评估的分子标志物:美国临床病理学会、美国病理学家学院、分子病理学会和美国临床肿瘤学会的指南。
J Clin Oncol. 2017 May 1;35(13):1453-1486. doi: 10.1200/JCO.2016.71.9807. Epub 2017 Feb 6.
8
Image-based surrogate biomarkers for molecular subtypes of colorectal cancer.基于图像的结直肠癌分子亚型替代生物标志物。
Bioinformatics. 2017 Jul 1;33(13):2002-2009. doi: 10.1093/bioinformatics/btx027.
9
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.结直肠癌的共识分子亚型与精准医学的演进。
Nat Rev Cancer. 2017 Feb;17(2):79-92. doi: 10.1038/nrc.2016.126. Epub 2017 Jan 4.
10
From tumour heterogeneity to advances in precision treatment of colorectal cancer.从肿瘤异质性到结直肠癌精准治疗的进展。
Nat Rev Clin Oncol. 2017 Apr;14(4):235-246. doi: 10.1038/nrclinonc.2016.171. Epub 2016 Dec 6.